
Krishna Institute of Medical S share price
NSE: KIMS · Healthcare
₹763.35 +4.62%
Closing price data, updated 17 Nov 2026. 52-week range: -11.0% from high, +32.6% above low.
Price₹763.35
Market cap₹32,061 Cr
P/E150.9
P/B8.15
ROE11.0%
ROCE8.1%
Debt / equity1.89
Dividend yield0.00%
EPS₹5.06
Book value₹93.61
Operating margin13.8%
Dipscan score26 / 100
Share: WhatsAppX / TwitterTelegram
Krishna Institute of Medical S shareholding pattern
As of Sep 2026: Promoters 32.66%, FIIs 15.01%, DIIs 33.22%, Government 0.00%, Public 11.83%, Others 7.28%.
| Holder | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 |
|---|---|---|---|---|---|---|
| Promoters | 32.66% | 32.50% | 32.50% | 34.11% | 34.11% | 34.11% |
| FIIs | 15.01% | 14.74% | 14.44% | 14.33% | 15.03% | 15.54% |
| DIIs | 33.22% | 34.43% | 34.59% | 32.71% | 32.12% | 31.66% |
| Government | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public | 11.83% | 11.22% | 11.84% | 11.76% | 11.72% | 11.58% |
| Others | 7.28% | 7.25% | 6.98% | 7.09% | 7.03% | 7.11% |
| No. of Shareholders | 95,609 | 95,710 | 93,333 | 101,599 | 104,872 | 108,955 |
As filed by the company with the exchanges.
Returns
| 1 day | 1 week | 1 month | 3 months | 6 months | 1 year |
|---|---|---|---|---|---|
| +4.62% | +5.58% | +10.16% | -5.47% | -1.29% | +13.88% |
Growth
| Sales growth, 3 years | +21.3% |
| Sales growth, 5 years | – |
| Profit growth, 3 years | -10.5% |
| Profit growth, 5 years | – |
| Latest quarter sales vs last year | +39.9% |
| Latest quarter profit vs last year | +12.1% |
Strengths and weaknesses
Strengths
- Company is expected to give good quarter
- Company's median sales growth is 21.9% of last 10 years
Weaknesses
- Stock is trading at 8.15 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
- Promoter holding has decreased over last 3 years: -6.20%
Peers in Healthcare
| Company | Price | Market cap | P/E | ROE | 1 year |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | ₹1,867.50 | ₹4,48,076 Cr | 40.9 | 14.7% | +8.8% |
| Divi's Laboratories Ltd. | ₹11,080.00 | ₹2,94,139 Cr | 87.5 | 16.2% | +69.4% |
| Torrent Pharmaceuticals Ltd. | ₹4,691.20 | ₹1,78,438 Cr | 84.0 | 27.1% | +22.6% |
| Apollo Hospitals Enterprise Lt | ₹8,771.00 | ₹1,26,114 Cr | 56.2 | 21.9% | +16.9% |
| Laurus Labs Ltd. | ₹2,220.00 | ₹1,19,949 Cr | 89.5 | 18.2% | +125.2% |
| Zydus Lifesciences Ltd. | ₹1,192.00 | ₹1,18,902 Cr | 28.4 | 19.7% | +27.0% |
| Dr. Reddy's Laboratories Ltd. | ₹1,377.90 | ₹1,14,778 Cr | 41.0 | 12.1% | +13.7% |
| Cipla Ltd. | ₹1,394.50 | ₹1,12,658 Cr | 38.9 | 11.8% | -8.0% |
Frequently asked questions
What is the share price of Krishna Institute of Medical S?
Krishna Institute of Medical S (KIMS) last closed at ₹763.35 (+4.62% on the day).
What is the market cap of Krishna Institute of Medical S?
About ₹32,061 Cr.
What is the P/E ratio of Krishna Institute of Medical S?
The price-to-earnings ratio is 150.9, and return on equity is 11.0%.
Figures are calculated from company results and exchange prices and are for information only.